EUVIMEDEUVIMED entdecken
Open Access

A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials

Daniel Abebayehu iD, Blaise N Pfaff iD, Grace C Bingham iD, Andrew E Miller iD, Mathew Kibet iD, Surabhi Ghatti, Donald R Griffin iD, Thomas H Barker iD

Science Advances · 2024

DOI: 10.1126/sciadv.adf2675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Daniel Abebayehu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Schools of Engineering and Medicine, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: Biocompatible Materials, Fibroblasts, Fibrosis, Hydrogels. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis-associated fibroblasts have been identified across various fibrotic disorders, but not in the context of biomaterials, fibrotic encapsulation, and the foreign body response. In other fibrotic disorders, a fibroblast subpopulation defined by Thy-1 loss is strongly correlated with fibrosis yet we do not know what promotes Thy-1 loss. We have previously shown that Thy-1 is an integrin regulator enabling normal fibroblast mechanosensing, and here, leveraging nonfibrotic microporous annealed particle (MAP) hydrogels versus classical fibrotic bulk hydrogels, we demonstrate that Thy1 −/− mice mount a fibrotic response to MAP gels that includes inflammatory signaling. We found that a distinct and cryptic α–smooth muscle actin–positive Thy-1 − fibroblast population emerges in response to interleuklin-1β (IL-1β) and tumor necrosis factor–α (TNFα). Furthermore, IL-1β/TNFα-induced Thy-1 − fibroblasts consist of two distinct subpopulations that are strongly proinflammatory. These findings illustrate the emergence of a unique proinflammatory, profibrotic fibroblast subpopulation that is central to fibrotic encapsulation of biomaterials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biocompatible MaterialsFibroblastsFibrosisHydrogelsThy-1 AntigensAnimalsMiceInterleukin-1betaMice, KnockoutTumor Necrosis Factor-alpha

Substanzen

Biocompatible MaterialsHydrogelsInterleukin-1betaThy-1 AntigensTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Schools of Engineering and Medicine, University of Virginia, Charlottesville, VA 22908, USA.
  • Robert Berne Cardiovascular Research Center, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
  • Department of Cell Biology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.

ORCID-Profile: Daniel Abebayehu, Blaise N Pfaff, Grace C Bingham, Andrew E Miller, Mathew Kibet, Donald R Griffin, Thomas H Barker

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Abebayehu, D., Pfaff, B. N., Bingham, G. C., Miller, A. E., Kibet, M., Ghatti, S., Griffin, D. R., & Barker, T. H. (2024). A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials. Science Advances. https://doi.org/10.1126/sciadv.adf2675

Vancouver

Abebayehu D, Pfaff BN, Bingham GC, Miller AE, Kibet M, Ghatti S, et al. A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials. Science Advances. 2024. doi:10.1126/sciadv.adf2675

BibTeX
@article{Abebayehu2024,
  author = {Abebayehu, Daniel and Pfaff, Blaise N and Bingham, Grace C and Miller, Andrew E and Kibet, Mathew and Ghatti, Surabhi and Griffin, Donald R and Barker, Thomas H},
  title = {A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adf2675}
}
Kostenlos starten →